I mean, our kids have their obituaries written, their end of life planning, their memorial service plan
It's one of the peptides that can be administered to help with specific health concerns and promote faster recovery
Dec 18, 2025, 08:00 ET CagriSema 2.4 mg/2.4 mg is an investigational fixed-dose injectable medicine that combines the novel amylin analogue, cagrilintide, with semaglutide to target complementary obesity-related pathways 1,2 In the REDEFINE 1 phase 3 trial, adults with obesity, or overweight with at least one obesity-related complication, taking CagriSema lost an average of 23% body weight when evaluating the treatment effect if all patients stayed on treatment *2 Novo Nordisk continues to build on its 100-year-plus legacy of science and innovation, with potential new treatments in obesity PLAINSBORO, N.J
Statements Author contributions B-WS: Conceptualization, Visualization, Writing original draft, Writing review & editing
Long-term continuous use lacks safety data, so periodic breaks are generally recommended
One patient observed the relief of feeling as if they were doing something active following long waiting periods